Abingdon Health PLC
OTC:ABDXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abingdon Health PLC
OTC:ABDXF
|
UK |
|
B
|
Bioharvest Sciences Inc
F:8MV
|
CA |
|
R
|
Reko International Group Inc
F:0VL
|
CA |
|
B
|
Bowleven PLC
F:BO2
|
UK |
|
B
|
Blue Cap AG
DUS:B7E
|
DE |
|
I
|
IXICO PLC
OTC:PHYOF
|
UK |
|
B
|
Beijing Enterprises Holdings Ltd
SWB:BJEB
|
HK |
|
Cypherpunk Holdings Inc
F:1X0
|
CA |
|
Servizi Italia SpA
LSE:0NJ3
|
IT |
|
S
|
Sdm SE
F:75S
|
DE |
|
A
|
Axfood AB
OTC:AXFOF
|
SE |
|
Leopalace21 Corp
OTC:LEOPF
|
JP |
|
V
|
Vistry Group PLC
F:44B
|
UK |
|
T
|
Texas Capital Bancshares Inc
SWB:TCA
|
US |
|
S
|
Schaeffler AG
XHAM:SHA0
|
DE |
|
Descente Ltd
OTC:DESLF
|
JP |
|
B
|
Beijing Urban Construction Design & Development Group Co Ltd
F:BDG
|
CN |
|
Ebara Corp
OTC:EBCOF
|
JP |
|
Z
|
Zanaga Iron Ore Company Ltd
SWB:6ZA
|
GG |
|
G
|
Gesco SE
SWB:GSC1
|
DE |
|
Q
|
Quantum Blockchain Technologies PLC
F:BYA1
|
UK |
|
L
|
Loungers PLC
F:LP0
|
UK |
|
C
|
Corestate Capital Holding SA
DUS:CCAP
|
LU |
|
G
|
Geox SpA
DUS:GHH
|
IT |
Wall St Price Targets
ABDXF Price Targets Summary
Abingdon Health PLC
According to Wall Street analysts, the average 1-year price target for
ABDXF is 0.5689 USD with a low forecast of 0.2676 USD and a high forecast of 0.8931 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABDXF's stock price target?
Price Target
0.5689
USD
According to Wall Street analysts, the average 1-year price target for
ABDXF is 0.5689 USD with a low forecast of 0.2676 USD and a high forecast of 0.8931 USD.
What is the Revenue forecast for Abingdon Health PLC?
Projected CAGR
26%
Over the last 7 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 26%.
What is the Gross Profit forecast for Abingdon Health PLC?
Projected CAGR
33%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 33%.